Hardware, Equipment & Parts
Compare Stocks
4 / 10Stock Comparison
NOVT vs COHR vs MKSI vs VIAV
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Communication Equipment
NOVT vs COHR vs MKSI vs VIAV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Communication Equipment |
| Market Cap | $4.86B | $50.62B | $20.25B | $11.81B |
| Revenue (TTM) | $981M | $1.81T | $4.07B | $1.37B |
| Net Income (TTM) | $54M | $191.68B | $327M | $-55M |
| Gross Margin | 44.4% | 0.1% | 45.2% | 55.7% |
| Operating Margin | 11.9% | 0.0% | 14.8% | 8.2% |
| Forward P/E | 38.2x | 59.5x | 30.4x | 55.2x |
| Total Debt | $342M | $3.89B | $4.69B | $692M |
| Cash & Equiv. | $381M | $909M | $675M | $424M |
NOVT vs COHR vs MKSI vs VIAV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Novanta Inc. (NOVT) | 100 | 132.7 | +32.7% |
| Coherent, Inc. (COHR) | 100 | 671.6 | +571.6% |
| MKS Inc. (MKSI) | 100 | 284.8 | +184.8% |
| Viavi Solutions Inc. (VIAV) | 100 | 440.5 | +340.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOVT vs COHR vs MKSI vs VIAV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOVT is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 2.02, Low D/E 26.0%, current ratio 3.69x
- PEG 11.61 vs VIAV's 12.09
COHR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 23.4%, EPS growth 71.7%, 3Y rev CAGR 20.5%
- 14.7% 10Y total return vs NOVT's 8.5%
- 23.4% revenue growth vs NOVT's 3.3%
- 10.6% margin vs VIAV's -4.0%
MKSI is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 2.64, yield 0.3%
- Beta 2.64, yield 0.3%, current ratio 2.71x
- Lower P/E (30.4x vs 55.2x)
- 0.3% yield, vs COHR's 0.0%, (2 stocks pay no dividend)
VIAV is the clearest fit if your priority is stability and momentum.
- Beta 1.54 vs COHR's 2.79
- +466.6% vs NOVT's +14.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.4% revenue growth vs NOVT's 3.3% | |
| Value | Lower P/E (30.4x vs 55.2x) | |
| Quality / Margins | 10.6% margin vs VIAV's -4.0% | |
| Stability / Safety | Beta 1.54 vs COHR's 2.79 | |
| Dividends | 0.3% yield, vs COHR's 0.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +466.6% vs NOVT's +14.6% | |
| Efficiency (ROA) | 4.4% ROA vs VIAV's -2.3%, ROIC 3.6% vs 5.5% |
NOVT vs COHR vs MKSI vs VIAV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NOVT vs COHR vs MKSI vs VIAV — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
COHR leads in 2 of 6 categories
NOVT leads 1 • MKSI leads 0 • VIAV leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
COHR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COHR is the larger business by revenue, generating $1.81T annually — 1846.3x NOVT's $981M. COHR is the more profitable business, keeping 10.6% of every revenue dollar as net income compared to VIAV's -4.0%. On growth, COHR holds the edge at +1204.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $981M | $1.81T | $4.1B | $1.4B |
| EBITDAEarnings before interest/tax | $179M | $913M | $945M | $207M |
| Net IncomeAfter-tax profit | $54M | $191.7B | $327M | -$55M |
| Free Cash FlowCash after capex | $48M | -$537.2B | $401M | $46M |
| Gross MarginGross profit ÷ Revenue | +44.4% | +0.1% | +45.2% | +55.7% |
| Operating MarginEBIT ÷ Revenue | +11.9% | +0.0% | +14.8% | +8.2% |
| Net MarginNet income ÷ Revenue | +5.5% | +10.6% | +8.0% | -4.0% |
| FCF MarginFCF ÷ Revenue | +4.9% | -29.7% | +9.8% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.5% | +1204.5% | +15.2% | +42.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.2% | +11190.8% | +53.2% | -70.2% |
Valuation Metrics
Evenly matched — NOVT and MKSI each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 68.8x trailing earnings, MKSI trades at a 80% valuation discount to VIAV's 340.3x P/E. Adjusting for growth (PEG ratio), NOVT offers better value at 28.13x vs VIAV's 74.57x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $4.9B | $50.6B | $20.2B | $11.8B |
| Enterprise ValueMkt cap + debt − cash | $4.8B | $53.6B | $24.3B | $12.1B |
| Trailing P/EPrice ÷ TTM EPS | 92.71x | -613.83x | 68.83x | 340.33x |
| Forward P/EPrice ÷ next-FY EPS est. | 38.25x | 59.48x | 30.36x | 55.18x |
| PEG RatioP/E ÷ EPS growth rate | 28.13x | — | — | 74.57x |
| EV / EBITDAEnterprise value multiple | 27.00x | 48.61x | 26.70x | 90.43x |
| Price / SalesMarket cap ÷ Revenue | 4.96x | 8.71x | 5.15x | 10.89x |
| Price / BookPrice ÷ Book value/share | 3.81x | 5.83x | 7.49x | 14.77x |
| Price / FCFMarket cap ÷ FCF | 100.38x | 262.58x | 40.74x | 190.52x |
Profitability & Efficiency
NOVT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-7 for VIAV. NOVT carries lower financial leverage with a 0.26x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), COHR scores 7/9 vs VIAV's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.1% | +6.9% | +12.2% | -6.9% |
| ROA (TTM)Return on assets | +3.0% | +4.4% | +3.7% | -2.3% |
| ROICReturn on invested capital | +7.4% | +3.6% | +6.5% | +5.5% |
| ROCEReturn on capital employed | +8.3% | +4.2% | +7.2% | +4.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.26x | 0.46x | 1.73x | 0.89x |
| Net DebtTotal debt minus cash | -$39M | $3.0B | $4.0B | $269M |
| Cash & Equiv.Liquid assets | $381M | $909M | $675M | $424M |
| Total DebtShort + long-term debt | $342M | $3.9B | $4.7B | $692M |
| Interest CoverageEBIT ÷ Interest expense | 4.89x | 0.01x | 2.84x | 2.70x |
Total Returns (Dividends Reinvested)
COHR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in COHR five years ago would be worth $50,156 today (with dividends reinvested), compared to $10,573 for NOVT. Over the past 12 months, VIAV leads with a +466.6% total return vs NOVT's +14.6%. The 3-year compound annual growth rate (CAGR) favors COHR at 114.9% vs NOVT's -5.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +22.6% | +64.3% | +78.8% | +181.3% |
| 1-Year ReturnPast 12 months | +14.6% | +358.5% | +306.1% | +466.6% |
| 3-Year ReturnCumulative with dividends | -15.2% | +892.8% | +266.0% | +461.0% |
| 5-Year ReturnCumulative with dividends | +5.7% | +401.6% | +66.5% | +212.0% |
| 10-Year ReturnCumulative with dividends | +853.7% | +1467.0% | +750.6% | +715.5% |
| CAGR (3Y)Annualised 3-year return | -5.3% | +114.9% | +54.1% | +77.7% |
Risk & Volatility
Evenly matched — MKSI and VIAV each lead in 1 of 2 comparable metrics.
Risk & Volatility
VIAV is the less volatile stock with a 1.54 beta — it tends to amplify market swings less than COHR's 2.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MKSI currently trades 92.0% from its 52-week high vs VIAV's 84.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.02x | 2.79x | 2.64x | 1.54x |
| 52-Week HighHighest price in past year | $149.95 | $364.80 | $326.83 | $60.43 |
| 52-Week LowLowest price in past year | $98.27 | $67.30 | $71.49 | $8.87 |
| % of 52W HighCurrent price vs 52-week peak | +90.9% | +87.5% | +92.0% | +84.5% |
| RSI (14)Momentum oscillator 0–100 | 62.6 | 64.4 | 65.3 | 66.7 |
| Avg Volume (50D)Average daily shares traded | 375K | 6.8M | 1.2M | 6.3M |
Analyst Outlook
Evenly matched — MKSI and VIAV each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NOVT as "Buy", COHR as "Buy", MKSI as "Buy", VIAV as "Buy". Consensus price targets imply 10.1% upside for NOVT (target: $150) vs -36.8% for VIAV (target: $32). MKSI is the only dividend payer here at 0.29% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $150.00 | $252.50 | $272.86 | $32.25 |
| # AnalystsCovering analysts | 3 | 29 | 29 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | +0.3% | — |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $0.07 | $0.87 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.8% | +0.1% | +0.2% | +0.1% |
COHR leads in 2 of 6 categories (Income & Cash Flow, Total Returns). NOVT leads in 1 (Profitability & Efficiency). 3 tied.
NOVT vs COHR vs MKSI vs VIAV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NOVT or COHR or MKSI or VIAV a better buy right now?
For growth investors, Coherent, Inc.
(COHR) is the stronger pick with 23. 4% revenue growth year-over-year, versus 3. 3% for Novanta Inc. (NOVT). MKS Inc. (MKSI) offers the better valuation at 68. 8x trailing P/E (30. 4x forward), making it the more compelling value choice. Analysts rate Novanta Inc. (NOVT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOVT or COHR or MKSI or VIAV?
On trailing P/E, MKS Inc.
(MKSI) is the cheapest at 68. 8x versus Viavi Solutions Inc. at 340. 3x. On forward P/E, MKS Inc. is actually cheaper at 30. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Novanta Inc. wins at 11. 61x versus Viavi Solutions Inc. 's 12. 09x.
03Which is the better long-term investment — NOVT or COHR or MKSI or VIAV?
Over the past 5 years, Coherent, Inc.
(COHR) delivered a total return of +401. 6%, compared to +5. 7% for Novanta Inc. (NOVT). Over 10 years, the gap is even starker: COHR returned +1467% versus VIAV's +715. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOVT or COHR or MKSI or VIAV?
By beta (market sensitivity over 5 years), Viavi Solutions Inc.
(VIAV) is the lower-risk stock at 1. 54β versus Coherent, Inc. 's 2. 79β — meaning COHR is approximately 81% more volatile than VIAV relative to the S&P 500. On balance sheet safety, Novanta Inc. (NOVT) carries a lower debt/equity ratio of 26% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NOVT or COHR or MKSI or VIAV?
By revenue growth (latest reported year), Coherent, Inc.
(COHR) is pulling ahead at 23. 4% versus 3. 3% for Novanta Inc. (NOVT). On earnings-per-share growth, the picture is similar: Viavi Solutions Inc. grew EPS 225. 0% year-over-year, compared to -16. 9% for Novanta Inc.. Over a 3-year CAGR, COHR leads at 20. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOVT or COHR or MKSI or VIAV?
MKS Inc.
(MKSI) is the more profitable company, earning 7. 5% net margin versus 0. 8% for Coherent, Inc. — meaning it keeps 7. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MKSI leads at 14. 4% versus 6. 5% for VIAV. At the gross margin level — before operating expenses — VIAV leads at 56. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOVT or COHR or MKSI or VIAV more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Novanta Inc. (NOVT) is the more undervalued stock at a PEG of 11. 61x versus Viavi Solutions Inc. 's 12. 09x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, MKS Inc. (MKSI) trades at 30. 4x forward P/E versus 59. 5x for Coherent, Inc. — 29. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOVT: 10. 1% to $150. 00.
08Which pays a better dividend — NOVT or COHR or MKSI or VIAV?
In this comparison, MKSI (0.
3% yield) pays a dividend. NOVT, COHR, VIAV do not pay a meaningful dividend and should not be held primarily for income.
09Is NOVT or COHR or MKSI or VIAV better for a retirement portfolio?
For long-horizon retirement investors, Coherent, Inc.
(COHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1467% 10Y return). MKS Inc. (MKSI) carries a higher beta of 2. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (COHR: +1467%, MKSI: +750. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOVT and COHR and MKSI and VIAV?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NOVT is a small-cap quality compounder stock; COHR is a mid-cap high-growth stock; MKSI is a mid-cap quality compounder stock; VIAV is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.